Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.40 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3396294 | 0.78 | PTGS1 (0.44) | PTGS1SLC7A11 | |
| SCHEMBL4872186 | 0.78 | PTGS1 (0.44) | PTGS1SLC7A11 | |
| SCHEMBL736616 | 0.75 | USP2 (0.39) | PTGS1SLC7A11PAX8 | |
| SCHEMBL2159077 | 0.74 | PAX8 (0.36) | PTGS1SLC7A11PAX8 | |
| SCHEMBL9384783 | 0.73 | PTGS1 (0.48) | PTGS1SLC7A11 | |
| SCHEMBL5055049 | 0.72 | PTGS1 (0.39) | PTGS1SLC7A11 | |
| SCHEMBL1373431 | 0.71 | PTGS1 (0.46) | PTGS1SLC7A11 | |
| SCHEMBL1045518 | 0.71 | — | — | |
| SCHEMBL28984792 | 0.71 | PTGS1 (0.46) | PTGS1SLC7A11 | |
| SCHEMBL9674473 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150023941-A1 | Compositions Comprising Sugar-Cysteine Products | EAST WEST BANK | 2015-01-22 | — | — | US | disclosed |
| US-20140348811-A1 | COMPOSITIONS COMPRISING SUGAR-CYSTEINE PRODUCTS | MAX INTERNATIONAL, LLC (US) | 2014-11-27 | — | — | US | disclosed |
| US-8853170-B2 | Compositions comprising sugar-cysteine products | MAX INTERNATIONAL, LLC (US) | 2014-10-07 | — | — | US | disclosed |
| WO-2013016636-A1 | COMPOSITIONS COMPRISING SUGAR-CYSTEINE PRODUCTS | MAX INTERNATIONAL, LLC (US) | 2013-01-31 | — | — | WO | disclosed |
| WO-2011149835-A1 | COMPOSITIONS AND BEVERAGES COMPRISING NUTRIENTS, VITAMINS, SUGARS, CYSTEINE, AND/OR SUGAR-CYSTEINE PRODUCTS | MAX INTERNATIONAL, LLC (US) | 2011-12-01 | — | — | WO | disclosed |
| US-20110287109-A1 | Compositions And Beverages Comprising Nutrients, Vitamins, Sugars, Cysteine, And/Or Sugar-Cysteine Products | MAX INTERNATIONAL, LLC (US) | 2011-11-24 | — | — | US | disclosed |
| WO-2011094491-A1 | COMPOSITIONS COMPRISING SUGAR-CYSTEINE PRODUCTS | MAX INTERNATIONAL, LLC (US) | 2011-08-04 | — | — | WO | disclosed |
| WO-2011094490-A1 | METHODS OF PREPARING THIAZOLIDINES | MAX INTERNATIONAL, LLC (US) | 2011-08-04 | — | — | WO | disclosed |
| US-20110183927-A1 | Compositions Comprising Sugar-Cysteine Products | MAX INTERNATIONAL, LLC (US) | 2011-07-28 | — | — | US | disclosed |
| US-20110184185-A1 | Methods Of Preparing Thiazolidines | MAX INTERNATIONAL, LLC (US) | 2011-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110184185-A1 | Methods Of Preparing Thiazolidines | RPIA, DPYD, TXN | PTGS1 2393/4885SLC7A11 469/4885PAX8 2269/4885 |
| US-20150023941-A1 | Compositions Comprising Sugar-Cysteine Products | CBS, CTH, GCLC | PTGS1 2672/4885SLC7A11 4/4885PAX8 3570/4885 |
| US-20140348811-A1 | COMPOSITIONS COMPRISING SUGAR-CYSTEINE PRODUCTS | CBS, CTH, GCLC | PTGS1 2672/4885SLC7A11 4/4885PAX8 3570/4885 |
| US-20110183927-A1 | Compositions Comprising Sugar-Cysteine Products | CBS, CTH, GCLC | PTGS1 2672/4885SLC7A11 4/4885PAX8 3570/4885 |
| US-20110287109-A1 | Compositions And Beverages Comprising Nutrients, Vitamins, Sugars, Cysteine, And/Or Sugar-Cysteine Products | CBS, PROC, SLC7A11 | PTGS1 1861/4885SLC7A11 3/4885PAX8 3426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.